Skip to main content
. 2017 Nov 8;75(1):56–64. doi: 10.1001/jamapsychiatry.2017.3379

Table 2. 6-Month Care Processes and Health Services Use Following Randomization.

Characteristic CCBT Alone (n = 301) CCBT+ISG (n = 302) Usual Care (n = 101)
Beating the Blues CCBT, No. (%)
Participants who logged in 261 (86.7) 260 (86.1) NA
CCBT sessions completed of those who completed ≥1 session, mean (SD) [denominator] 5.4 (2.8) [254] 5.5 (2.7) [250] NA
No. of participants who completed all 8 sessions 112 (37.2) 109 (36.1) NA
ISG
Logged in, No. (%) NA 228 (75.5) NA
Log-ins per user
Mean NA 8.9 NA
Median (range) NA 4 (1-214) NA
Commented, No. (%) NA 138 (45.7) NA
Comments per commenter
Mean NA 9.6 NA
Median (range) NA 3 (1-285) NA
Posted, No. (%) NA 45 (14.9) NA
Posts per poster
Mean NA 3.8 NA
Median (range) NA 1 (1-42) NA
Commented or posted, No. (%) NA 141 (46.7) NA
Comments/posts per commenter/poster
Mean NA 10.5 NA
Median (range) NA 3 (1-306) NA
Care management, median (IQR)a
No. of telephone calls 4 (3-6) 3 (2-5) NA
No. of emails 9 (6-11) 12 (9-16) NA
No. of total contacts 13 (10-16) 16 (12-20) NA
Pharmacotherapy, No. (%)a
SSRI/SNRI use at baseline 200 (66.4) 206 (68.2) 66 (65.3)
SSRI/SNRI use at 6 mo, No./total No. (%) 164/253 (64.8) 166/259 (64.1) 50/92 (54)
Benzodiazepine use at baseline 39 (13.0) 40 (13.2) 14 (13.9)
Benzodiazepine use at 6 mo, No./total No. (%) 31/253 (12.3) 29/259 (11.2) 9/92 (10)
Health care use, median (range)a
PCP office visits 2 (0-12) 2 (0-16) 2 (0-7)
PCP telephone contacts 0 (0-7) 0 (0-7) 0 (0-4)
PCP email contacts 0 (0-7) 0 (0-11) 0 (0-6)
PCP total contacts 3 (0-18) 4 (0-28) 3 (0-11)
Mental health specialty visit, No./total No. (%) 45/267 (16.9) 69/271 (25.5) 17/95 (18)
ED visits 0 (0-5) 0 (0-7) 0 (0-4)
Hospitalizations 0 (0-4) 0 (0-2) 0 (0-3)

Abbreviations: CCBT, computerized cognitive behavioral therapy; ED, emergency department; IQR, interquartile range; ISG, internet support group; NA, not applicable; PCP, primary care physician; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin norepinephrine reuptake inhibitor.

a

Data from medical record abstraction.